Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China

Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China

BackgroundsRobust evidence have demonstrated the beneficial effect of Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in T2D patients with cardiovascular diseases and chronic kidney disease. Multiple studies analyzed patterns and predictors...

Full description

Bibliographic Details
Main Authors: Cao Li, Shanshan Guo, Jiping Huo, Yiming Gao, Yilong Yan, Zhigang Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Endocrinology
Subjects:
SGLT2i
GLP-1RA
type 2 diabetics
cardiovascular diseases
chronic kidney disease
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.987081/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.987081/full

Similar Items